Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia
1 Views
administrator
07/08/23
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.
More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance
-
Category
Show more
Facebook Comments
No comments found